Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

19-NEU-3855-Exoskeleton-650×450
July 31, 2019/Neurosciences/Research

Piloting a Powered Exoskeleton for Gait Training in Multiple Sclerosis

New study aims to assess a potential new indication for the technology

19-NEU-4042-social-buzz-650×450
July 22, 2019/Basic & Translational Science

Can Social Media Buzz Increase Your Academic Citations?

Study looks for correlations in neurology research

19-NEU-318 T-cell-activation-650×450
July 19, 2019/Basic & Translational Science

Grant Boosts Efforts to Take on Glioblastoma by Targeting Immunosuppressive Cells

Focus is on inhibiting action of myeloid-derived suppressor cells

Self-portrait
July 15, 2019/Neurosciences/Research

Tardive Dyskinesia Therapy Holds Up Over Long-Term Assessment

Extension study of VMAT2 inhibitor helps confirm a new therapeutic era

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Post-Stroke-Brain-Stimulation-2
July 8, 2019/Neurosciences/Research

Trial Explores Combination of Contralesional Brain Stimulation and Neuromuscular Stimulation for Post-Stroke Upper Limb Paresis

NIH-funded clinical study pairs up two innovative techniques

19-NEU-462-DeSilva-Leverenz-Alzheimers-CQD-650×450
June 21, 2019/Basic & Translational Science

Probing the Innate Immune System’s Role in Alzheimer’s Disease

Interdisciplinary research aims to glean insights for therapeutic translation

19-NEU-319-Caren-Treadmill-MS-650×450
June 4, 2019/Neurosciences/Research

Virtual Reality Platform’s Dynamic Approach to Physical Therapy Yields Benefits in MS

Preliminary study finds improved gait and balance vs. traditional PT

650×450-Stationery-Bike-Parkinsons
May 30, 2019/Neurosciences/Research

Can Exercise Alter Parkinson Disease Progression? NIH Award Launches First Long-Term Study to Find Out

Study to assess effects of 12 months of home-based cycling

19-NEU-321-excessive-sleepiness-650×450
May 9, 2019/Neurosciences/Research

Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial

New drug for adults with OSA or narcolepsy expected to launch soon

19-NEU-320-RNS-neurostimulation-650×450
May 8, 2019/Neurosciences/Research

Seizure Reductions with Responsive Neurostimulation Grow Over Time, Long-Term Study Shows

75% median reduction in seizures observed over 9 years of treatment

BackPage 8 of 21Next

Advertisement

Ad